Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
About
In The Last Decade
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
597 papers receiving 20.5k citations
Fields of papers published by authors at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
This network shows the impact of papers affiliated with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers at the time of their publication.
Countries citing scholars working at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
This map shows the geographic impact of research produced by authors working at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers more than expected).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.